Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity
- 1 August 2000
- journal article
- Published by Microbiology Society in Journal of General Virology
- Vol. 81 (8) , 1975-1981
- https://doi.org/10.1099/0022-1317-81-8-1975
Abstract
Genital human papillomaviruses (HPV) are considered to be one of the main risk factors for the development of cervical cancer. The P97 promoter at the E6-proximal end of the long control region (LCR) regulates the transcription of viral genes, especially the oncogenes E6 and E7. The LCR contains binding sites of several viral and cellular transcription factors, which either activate or repress the P97 promoter. Intratype variants of HPV-16 belong to six geographically clustered phylogenetic groups distributed all over the world. These variants exhibit differences in E6 protein activities and in tumour progression in vivo. Seven HPV-16 variants were investigated by sequencing the entire LCR (nt 7060–124) and by comparing the transcriptional activities of their P97 promoters. Previously unknown nucleotide variations were identified in all LCRs investigated. In luciferase assays, 3·3- and 2·8-fold increases in P97 promoter activity were detected in the Asian American c and North American 1 variants when compared with the European reference clone. The African variants 1a and 2a exhibited P97 promoter activities comparable to the European reference clone. After recombining different LCR fragments, the region responsible for enhanced transcription in the Asian American c and North American 1 variants could be attributed to the E6-proximal end of the LCR (nt 7619–124).Keywords
This publication has 42 references indexed in Scilit:
- Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalitiesInternational Journal of Cancer, 1996
- Transcriptional Activity of Human Papillomavirus Type 31b Enhancer Is Regulated through Synergistic Interaction of AP1 with Two Novel Cellular FactorsVirology, 1995
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- Prevalence of deletions of YY1‐binding sites in episomal HPV 16 DNA from cervical cancersInternational Journal of Cancer, 1994
- Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesionsJournal of General Virology, 1992
- The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex.Genes & Development, 1991
- Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promotors through AP1 binding sitesNucleic Acids Research, 1990
- Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancersNucleic Acids Research, 1990
- The Human Papilloma Virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene ProductScience, 1989
- Firefly luciferase gene: structure and expression in mammalian cells.Molecular and Cellular Biology, 1987